USFDA completes inspections at Torrent Pharmaceuticals’ Gujarat manufacturing facility

13 Jun 2024 Evaluate

The United States Food and Drug Administration (USFDA) has completed Pre-Approval Inspection (PAI) and a GMP inspection at Torrent Pharmaceuticals’ manufacturing facility situated in Indrad, Gujarat. The Inspection was conducted from June 03, 2024 to June 12, 2024. 

At the end of the inspection, the Company was issued a Form 483 with 5 observations. There was no observation related to data integrity reported. The company will respond to the USFDA within the prescribed time-frame and will work in close collaboration with the agency to address the observations at the earliest possible time.

Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3170.55 66.00 (2.13%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.